ADVANTAGES OF ACNE THERAPY BY ORAL CONTRACEPTIVES
https://doi.org/10.21518/2079-701X-2017-11-88-90
Abstract
The article provides epidemiologic data on acne in women, an interrelation of the disease with hormonal processes and disturbances is described. Results of complex therapy of 49 patients with acne by folate-containing oral contraceptives. Therapy effect not only on the skin process but on the psychoemotional and physical status of patients is noted. The subjective evaluation of patients confirms high effectiveness of the proposed therapy.
About the Authors
I. M. Korsunskaya
Center of Theoretic Problems of Physical and Chemical Pharmacology of the Russian Academy of Sciences
Russian Federation
Russian Federation
MD, Prof.
Moscow
E. V. Dvoryankova
Center of Theoretic Problems of Physical and Chemical Pharmacology of the Russian Academy of Sciences; Family Medical Center Pangea
Russian Federation
Russian Federation
MD.
Moscow
References
1. Orion E, Wolf R. Psychological factors in skin diseases: stress and skin: facts and controversies. Clin Dermatol, 2013, 31(6): 707–11.
2. Адаскевич И.П. Акне вульгарные и розовые. Н. Новгород: Издательство НГМА, 2003. 160 с.
3. Самцов А.В. Клинические особенности течения акне у женщин. Вестник дерматологии и венерологии, 2012, 6: 60-62.
4. Collier C, Harper J, Cafardi J et al. The prevalence of acne in adults 20 years and older. J Am Acad Dermatol, 2008, 58: 56-59.
5. Goulden V, Stables GI, Cunliffe WJ. Prevalence of facial acne in adults. J Am Acad Dermatol, 1999, 41: 577-580.
6. Shaw J, White L. Persistant acne in adult women. Arch Dermatol, 2001, 137: 1252-1253.
7. Гунина Н.В., Масюкова С.А., Пищулин А.А. Роль половых стероидных гормонов в патогенезе акне. Экспериментальная и клиническая дерматокосметология, 2005, 5: 55-62.
8. Роговская С.И., Телунц А.В., Савельева И.С. Акне как проявление синдрома гиперандрогении: методы коррекции. Provisorum, 2002, 8: 28-30.
9. Zouboulis CC. The human skin as a hormone target and an endocrine gland. Hormones (Athens), 2004, 3(1): 9-26.
10. Thiboutot D, Martin P, Volikos L, Gilliland K. Oxidative activity of the type 2 isozyme of 17beta-hydroxysteroid dehydrogenase (17betaHSD) predominates in human sebaceous glands. J. Invest. Dermatol., 1998, 111(3): 390-395.
11. Thiboutot D. Overview of acne and its treatment. Cutis, 2008, 81(S1): 3-7.
12. Haider A, Shaw JC. Treatment of acne vulgaris. JAMA, 2004, 292(6):726-735.
13. Clarke S, Nelson A, George R, et al. Pharmacologic modulation of sebaceous gland activity: Mechanisms and clinical applications. Dermatol Clin., 2007, 25: 137-146.
14. Williams C, Layton AM. Persistent acne in women: implications for the patient and for therapy. Am. J. Clin. Dermatol., 2006, 7: 281-290.
15. Rivera R, Guerra A. Management of acne in women over 25 years of age. Actas Dermosifiliogr, 2009, 100: 33–37.
16. Монахов С.А. Комплексная терапия акне. Экспериментальная и клиническая дерматокосметология, 2008, 2: 29-34.
17. Redmond GP, Olson WH, Lippman JS et al. Effectiveness of norgestimate and ethinyl еstradiol in treating moderate acne vulgaris. J Acad Dermatol, 1997, 37: 746-754.
18. Монахов С.А. Фолатсодержащие антиандрогенные оральные контрацептивы: дерматологические аспекты. Гинекология, 2016, 18(4): 54-58.
19. Джес Плюс. Монография по продукту. М.: Bayer HealthCare, 2012.
20. Кузнецова И.В., Коновалов В.А. Фолиевая кислота и ее роль в женской репродукции. Гинекология, 2014, 16(4): 17-23.
Review
For citations:
Korsunskaya IM, Dvoryankova EV. ADVANTAGES OF ACNE THERAPY BY ORAL CONTRACEPTIVES. Meditsinskiy sovet = Medical Council. 2017;(11):88-90. (In Russ.) https://doi.org/10.21518/2079-701X-2017-11-88-90
Views:
834
Email this article 